Log in
Enquire now
Shift Bioscience

Shift Bioscience

Shift Bioscience is an AI-driven cell simulation platform founded in 2017 by Daniel Ives.

OverviewStructured DataIssuesContributors

Contents

shiftbioscience.com
Is a
Organization
Organization
Company
Company

Company attributes

Industry
Human Longevity
Human Longevity
Biomedical engineering
Biomedical engineering
Cardiovascular disease
Cardiovascular disease
‌
Anti-Aging
Cardiology
Cardiology
Internal medicine
Internal medicine
Medicine
Medicine
Biotechnology
Biotechnology
...
Location
Cambridge, Cambridgeshire
Cambridge, Cambridgeshire
B2X
B2B
B2B
CEO
‌
Daniel Ives
Founder
‌
Brendan Swain
‌
Daniel Ives
Pitchbook URL
pitchbook.com/profiles...226990-90
Number of Employees (Ranges)
11 – 50
Email Address
hello@shiftbioscience.com0
Full Address
Moneta (Building 280) Babraham Research Campus Cambridge CB22 2AT United Kingdom0
Investors
F-Prime Capital Partners
F-Prime Capital Partners
Kindred Capital
Kindred Capital
BGF
BGF
Founded Date
2017
Total Funding Amount (USD)
16,000,000
Latest Funding Round Date
October 15, 2024
Latest Funding Type
Seed
Seed
Country
United Kingdom
United Kingdom

Other attributes

Company Operating Status
Active
Latest Funding Round Amount (USD)
16,000,000
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Shift Bioscience

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Pricing
  • Enterprise

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.